Clinical Trial Update: Phase II Clinical Trial of Chidamide Combined With AK112 for Second-line and Advanced Bone and Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating chidamide in combination with AK112 for second-line and advanced soft tissue and bone sarcoma. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Sarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• AK112
• Chidamide (chidamide)

Snippet

Sponsor: Shanxi Province Cancer Hospital | Conditions: Sarcoma,Soft Tissue, Sarcoma | Phase 2 | Status: RECRUITING